Global Molecular Diagnostics Market Is Expected to Reach US $11.4 Billion by 2022; Finds New Report
Global Molecular Diagnostics Market - Focus on Infectious Diseases (HPV/Chlamydia/Gonorrhea) & Genetic Testing (HLA) - Industry Outlook 2022, there has been unprecedented rise in sexually infected diseases such as Chlamydia and Gonorrhea, particularly in the US. CT/NG is most prevalent sexually transmitted diseases (STD) in the US with consistent rise in the number of Chlamydia and Gonorrhea cases. The Government has also recommended regular screening for patients belonging to two of the major segments of the molecular diagnostics market: HPV...
View full press release